{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:36:08Z","timestamp":1771943768719,"version":"3.50.1"},"reference-count":27,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCO"],"published-print":{"date-parts":[[2020,4,24]]},"DOI":"10.5306\/wjco.v11.i4.243","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T10:29:56Z","timestamp":1587551396000},"page":"243-249","source":"Crossref","is-referenced-by-count":5,"title":["Personalized chemotherapy in clear cell adenocarcinoma of the urethra: A case report"],"prefix":"10.5306","volume":"11","author":[{"given":"Lisa B E","family":"Shields","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash Rezazadeh","family":"Kalebasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-012-1363-3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2484\/rcr.v6i3.490"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.16929"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.11.023"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/790235"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.09.064"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000443020"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.226734"},{"key":"ref9","unstructured":"Oliva E, Young RH. Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases. Mod Pathol 1996; 9: 513-520"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(98)00199-x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.014"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-001-0072-y"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4762"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060570"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a12e09"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23987"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1083"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-48"},{"key":"ref20","unstructured":"Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 1999; 5: 2048-2058"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Durbecq V, Paesmans M, Cardoso F, Desmedt C, Di Leo A, Chan S, Friedrichs K, Pinter T, Van Belle S, Murray E, Bodrogi I, Walpole E, Lesperance B, Korec S, Crown J, Simmonds P, Perren TJ, Leroy JY, Rouas G, Sotiriou C, Piccart M, Larsimont D. Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Mol Cancer Ther 2004; 3: 1207-1214","DOI":"10.1158\/1535-7163.1207.3.10"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00752.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.044"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.068"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Dalbagni G, Donat SM, Eschw\u00e8ge P, Herr HW, Zelefsky MJ. Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol 2001; 166: 1759-1761","DOI":"10.1016\/S0022-5347(05)65669-8"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2012.01.011"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2003.00629.x"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v11\/i4\/243.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T01:08:49Z","timestamp":1666400929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v11\/i4\/243.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,24]]}},"URL":"https:\/\/doi.org\/10.5306\/wjco.v11.i4.243","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}